Expansion Opportunity AmplifyBio is expanding coast to coast with facilities in Ohio and recent activity in South San Francisco and New Albany, signaling ongoing growth and potential for CDMO collaborations, site services, and regionalized supply chain partnerships.

Covert EM Partnerships Recent strategic collaborations with Silo Pharma and Xcell Biosciences indicate a strong appetite for joint development and manufacturing, suggesting opportunities to propose shared manufacturing, process optimization, and tech transfer services for cell and gene therapies.

Manufacturing Enablement The newly opened Manufacturing Enablement Center in New Albany and the large GLP lab footprint imply demand for scale-up support, analytical services, and GMP-compliant manufacturing capabilities, ideal for accelerated program timelines.

Therapy Focus AmplifyBio’s focus on T-cell receptor therapies and solid tumor programs creates opportunities to offer specialized manufacturing, characterization, and regulatory support services tailored to complex cell therapies.

Risk & Compliance Recent layoff notification litigation and cost-cutting moves highlight potential risk areas; position as a trusted partner offering compliance, workforce optimization, and risk assessment consulting to help stabilize programs and protect timelines.